← SageRanks

Fisher on the BEL20

This ranking weighs Revenue growth ×4, Analyst upside ×3, Buy % ×2, Gross margin ×2, and nothing else, across the 20 companies we track on the BEL20. Fisher set no numeric limits at all, so no company here is ever flagged: his fifteen points are qualitative.

Ranked highest by Fisher on this market right now, which is not the same list as the one that clears the limits above:

  1. Aedifica (AED.BR) · Real Estate · Revenue growth 104.3% · Analyst upside 26.4% · Buy % 80% · Gross margin 92%
  2. UCB (UCB.BR) · Healthcare · Revenue growth 22.5% · Analyst upside 41.3% · Buy % 75% · Gross margin 76%
  3. WDP (WDP.BR) · Real Estate · Revenue growth 16.4% · Analyst upside 27.8% · Buy % 73% · Gross margin 89%
  4. argenx (ARGX.BR) · Healthcare · Revenue growth 59.3% · Analyst upside 17.8% · Buy % 87% · Gross margin 59%
  5. Elia Group (ELI.BR) · Utilities · Revenue growth 18.0% · Analyst upside 26.8% · Buy % 73% · Gross margin 61%

From data as of 2026-09-11 03:00:56 UTC. Rebuilt every hour; the table above is live.

All 20 companies on the BEL20, ranked by Fisher, as text
  1. Aedifica (AED.BR) · Revenue growth 104.3% · Analyst upside 26.4% · Buy % 80% · Gross margin 92%
  2. UCB (UCB.BR) · Revenue growth 22.5% · Analyst upside 41.3% · Buy % 75% · Gross margin 76%
  3. WDP (WDP.BR) · Revenue growth 16.4% · Analyst upside 27.8% · Buy % 73% · Gross margin 89%
  4. argenx (ARGX.BR) · Revenue growth 59.3% · Analyst upside 17.8% · Buy % 87% · Gross margin 59%
  5. Elia Group (ELI.BR) · Revenue growth 18.0% · Analyst upside 26.8% · Buy % 73% · Gross margin 61%
  6. Montea (MONT.BR) · Revenue growth 11.1% · Analyst upside 22.7% · Buy % 67% · Gross margin 87%
  7. AB InBev (ABI.BR) · Revenue growth 11.0% · Analyst upside 21.1% · Buy % 80% · Gross margin 56%
  8. D'Ieteren (DIE.BR) · Revenue growth 3.4% · Analyst upside 38.0% · Buy % 100% · Gross margin 25%
  9. GBL (GBLB.BR) · Analyst upside 18.0% · Buy % 71% · Gross margin 71%
  10. Sofina (SOF.BR) · Analyst upside 17.3% · Buy % 100%
  11. Umicore (UMI.BR) · Revenue growth 60.1% · Analyst upside 15.9% · Buy % 53% · Gross margin 8%
  12. Lotus Bakeries (LOTB.BR) · Revenue growth 14.0% · Analyst upside 3.1% · Buy % 50% · Gross margin 40%
  13. Ageas (AGS.BR) · Revenue growth 27.5% · Analyst upside -1.1% · Buy % 25% · Gross margin 27%
  14. Melexis (MELE.BR) · Revenue growth 2.6% · Analyst upside 17.1% · Buy % 43% · Gross margin 39%
  15. Ackermans & van Haaren (ACKB.BR) · Revenue growth -0.1% · Analyst upside 16.3% · Buy % 57% · Gross margin 41%
  16. KBC (KBC.BR) · Revenue growth 6.6% · Analyst upside 0.2% · Buy % 32%
  17. Syensqo (SYENS.BR) · Revenue growth 4.1% · Analyst upside 1.5% · Buy % 50% · Gross margin 31%
  18. Azelis (AZE.BR) · Revenue growth 0.3% · Analyst upside 12.8% · Buy % 57% · Gross margin 23%
  19. Colruyt (COLR.BR) · Revenue growth 1.7% · Analyst upside -8.2% · Buy % 30% · Gross margin 29%
  20. Solvay (SOLB.BR) · Revenue growth -5.9% · Analyst upside -4.3% · Buy % 13% · Gross margin 21%